Chemotherapy before liver resection of colorectal metastases: friend or foe?

Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol (2012) 1.15

Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg (2015) 1.09

A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases. HPB (Oxford) (2013) 0.94

Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy. World J Surg (2013) 0.90

The association between preoperative chemotherapy and the prevalence of hepatic steatosis in hepatectomy for metastatic colorectal cancer. Arq Bras Cir Dig (2014) 0.84

Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? World J Gastroenterol (2015) 0.83

Oxaliplatin toxicity presenting as a liver nodule - case report. BMC Cancer (2015) 0.82

Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer. Br J Cancer (2013) 0.82

Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis. Int J Clin Exp Pathol (2012) 0.81

Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience. HPB Surg (2013) 0.79

Impact of hepatic lymph node metastasis on survival of patients with synchronous resectable or unresectable liver metastases of colorectal cancer. Tech Coloproctol (2012) 0.78

Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial. BMC Cancer (2015) 0.78

Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. Eur Radiol (2015) 0.78

The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer. J Res Med Sci (2014) 0.77

Liver angulometry: a simple method to estimate liver volume and ratios. HPB (Oxford) (2013) 0.76

Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases: an analysis of the LiverMetSurvey. HPB (Oxford) (2014) 0.76

Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol (2016) 0.76

Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes. Clin Exp Metastasis (2016) 0.76

ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE). World J Surg (2017) 0.76

Effect of preoperative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume. World J Surg Oncol (2013) 0.75

Global Proteome Changes in Liver Tissue 6 Weeks after FOLFOX Treatment of Colorectal Cancer Liver Metastases. Proteomes (2016) 0.75

Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. J Am Coll Surg (2017) 0.75

Pathological complete response after neoadjuvant chemotherapy for rectal cancer with synchronous multiple liver metastases: a report of an unusual case. Surg Case Rep (2016) 0.75

Hepatocellular carcinoma incidentally detected at second hepatectomy for repeated colorectal liver metastasis in a patient with hepatitis C virus-related cirrhosis: a case report. J Med Case Rep (2016) 0.75

Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice. Oncotarget (2016) 0.75

Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis. HPB (Oxford) (2012) 0.75

Unresolved issues and controversies surrounding the management of colorectal cancer liver metastasis. World J Surg Oncol (2015) 0.75

Reply to letter: "chemotherapy before liver resection of colorectal metastases: friend or foe?". Ann Surg (2015) 0.75

CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy? United European Gastroenterol J (2015) 0.75

Sinusoidal obstruction syndrome in the animal model: influence on liver surgery. Langenbecks Arch Surg (2016) 0.75

Centralization of Liver Cancer Surgery and Impact on Multidisciplinary Teams Working on Stage IV Colorectal Cancer. Oncol Rev (2017) 0.75

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13

Obesity in general elective surgery. Lancet (2003) 7.22

No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57

Kidney transplantation from donors without a heartbeat. N Engl J Med (2002) 4.85

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology (2009) 4.03

Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg (2012) 3.87

ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg (2014) 3.60

Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg (2006) 3.35

TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell (2010) 3.25

Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med (2008) 3.10

Evaluation and stages of surgical innovations. Lancet (2009) 3.04

Platelet-derived serotonin mediates liver regeneration. Science (2006) 2.98

New staging system and a registry for perihilar cholangiocarcinoma. Hepatology (2011) 2.89

Challenges in evaluating surgical innovation. Lancet (2009) 2.86

A multicenter randomized clinical trial of primary anastomosis or Hartmann's procedure for perforated left colonic diverticulitis with purulent or fecal peritonitis. Ann Surg (2012) 2.82

A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell (2009) 2.64

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest (2006) 2.63

Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg (2007) 2.53

What is a surgical complication? World J Surg (2008) 2.53

Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg (2004) 2.49

Protective strategies against ischemic injury of the liver. Gastroenterology (2003) 2.37

Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36

The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg (2013) 2.27

Donor information for living donor liver transplantation: where can comprehensive information be found? Liver Transpl (2012) 2.21

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg (2005) 2.18

How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg (2005) 2.16

Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant (2005) 2.06

Trainee satisfaction in surgery residency programs: modern management tools ensure trainee motivation and success. Surgery (2011) 2.04

Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World J Surg (2015) 1.95

Prospective evaluation of vacuum-assisted closure in abdominal compartment syndrome and severe abdominal sepsis. J Am Coll Surg (2007) 1.94

Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol (2006) 1.87

Atraumatic chylous ascites: systematic review on symptoms and causes. J Am Coll Surg (2011) 1.83

Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis (2007) 1.80

Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg (2006) 1.79

From abstract to impact in cardiovascular research: factors predicting publication and citation. Eur Heart J (2012) 1.79

Superiority of small islets in human islet transplantation. Diabetes (2007) 1.76

Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75

The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl (2011) 1.75

Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II). J Clin Oncol (2012) 1.73

The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J (2006) 1.73

Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients. Ann Surg (2010) 1.73

The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg (2011) 1.69

Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg (2014) 1.69

Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding. Ann Surg (2003) 1.67

Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc Natl Acad Sci U S A (2011) 1.66

Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg (2004) 1.65

Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med (2006) 1.65

The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery. Surgery (2009) 1.63

Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm Bowel Dis (2008) 1.61

MRI: the new reference standard in quantifying hepatic steatosis? Gut (2011) 1.61

Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02). Onkologie (2009) 1.58

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl (2002) 1.58

Hyperlipidemic myeloma: review of 53 cases. Ann Hematol (2009) 1.57

Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg (2009) 1.56

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut (2011) 1.56

Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg (2008) 1.55

Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell (2012) 1.55

Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J (2007) 1.53

Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion. Liver Transpl (2013) 1.49

Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. Gastroenterology (2010) 1.46

Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn's disease. Eur J Gastroenterol Hepatol (2014) 1.46

Serotonin regulates amylase secretion and acinar cell damage during murine pancreatitis. Gut (2012) 1.44

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. J Clin Oncol (2002) 1.44

Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation (2008) 1.43

Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology (2012) 1.43

Rare PIK3CA hotspot mutations in carcinomas of the biliary tract. Genes Chromosomes Cancer (2008) 1.43

Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg (2007) 1.42

Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology (2002) 1.42

Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42

Systemic protection through remote ischemic preconditioning is spread by platelet-dependent signaling in mice. Hepatology (2014) 1.42

Novel approach using dissecting sealer for uncinate process resection during pancreaticoduodenectomy. J Am Coll Surg (2006) 1.40

New device for the introduction of a circular stapler in laparoscopic gastric bypass surgery. Obes Surg (2006) 1.40

A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg (2006) 1.39

Laparoscopic partial splenectomy. J Am Coll Surg (2006) 1.39

Diagnostic performance of a non-contrast-enhanced magnetic resonance imaging protocol for potential living related kidney donors. Acad Radiol (2013) 1.38

Retroperitoneal perforation of the colon caused by colonic tuberculosis: report of a case. Dis Colon Rectum (2004) 1.38

Oxaliplatin: bimonthly, biweekly, or semimonthly? J Clin Oncol (2002) 1.38

ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology (2003) 1.37

Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology (2007) 1.35

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer (2006) 1.35

Robotic-assisted versus laparoscopic cholecystectomy: outcome and cost analyses of a case-matched control study. Ann Surg (2008) 1.35

Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. Hepatology (2009) 1.31

Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg (2002) 1.29

A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg (2008) 1.28

Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg (2003) 1.27

Omega 3 - Omega 6: What is right for the liver? J Hepatol (2007) 1.26

Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 1.26

Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology (2010) 1.25

Assessment of a novel screening score for nutritional risk in predicting complications in gastro-intestinal surgery. Clin Nutr (2008) 1.24

Stapled vs excision hemorrhoidectomy: long-term results of a prospective randomized trial. Arch Surg (2002) 1.22

Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial. Ann Surg (2008) 1.21